Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer

Stephen Jones, C. Vogel, A. Arkhipov, L. Fehrenbacher, P. Eisenberg, B. Cooper, S. Honig, A. Polli, F. Whaley, E. Di Salle, J. Tiffany, A. Consonni, L. Miller

Research output: Contribution to journalArticlepeer-review

111 Scopus citations

Fingerprint Dive into the research topics of 'Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences